Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03920839
Title INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

malignant pleural mesothelioma

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Carboplatin + Paclitaxel + Retifanlimab

Cisplatin + Gemcitabine + Retifanlimab

Cisplatin + Pemetrexed Disodium + Retifanlimab

Carboplatin + Pemetrexed Disodium + Retifanlimab

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field